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Abstract
Background: Cross-presentation by dendritic cells (DCs) is a crucial prerequisite for effective priming of cytotoxic T-cell
responses against bacterial, viral and tumor antigens; however, this antigen presentation pathway remains poorly defined.
Methodology/Principal Findings: In order to develop a comprehensive understanding of this process, we tested the
hypothesis that the internalization of MHC class I molecules (MHC-I) from the cell surface is directly involved in cross-
presentation pathway and the loading of antigenic peptides. Here we provide the first examination of the internalization of
MHC-I in DCs and we demonstrate that the cytoplasmic domain of MHC-I appears to act as an addressin domain to route
MHC-I to both endosomal and lysosomal compartments of DCs, where it is demonstrated that loading of peptides derived
from exogenously-derived proteins occurs. Furthermore, by chasing MHC-I from the cell surface of normal and transgenic
DCs expressing mutant forms of MHC-I, we observe that a tyrosine-based endocytic trafficking motif is required for the
constitutive internalization of MHC-I molecules from the cell surface into early endosomes and subsequently deep into
lysosomal peptide-loading compartments. Finally, our data support the concept that multiple pathways of peptide loading
of cross-presented antigens may exist depending on the chemical nature and size of the antigen requiring processing.
Conclusions/Significance: We conclude that DCs have ‘hijacked’ and adapted a common vacuolar/endocytic intracellular
trafficking pathway to facilitate MHC I access to the endosomal and lysosomal compartments where antigen processing and
loading and antigen cross-presentation takes place.
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Introduction
In order to generate appropriate CD8
+ T cell-mediated
immune responses to viral, bacterial, self, or tumor-associated
protein antigens, professional antigen-presenting cells (pAPCs)
must acquire these antigens from the extracellular milieu, process
them into antigenic peptides, load them onto MHC class I (MHC-
I) molecules, and present them at the cell surface [1–4]. This
process of ‘‘cross-presentation’’ is known to occur most efficiently
in dendritic cells (DCs), but several mechanistic details remain
unclear.
Three non-mutually exclusive pathways have been proposed to
explain cross-presentation. In the vacuolar pathway, DCs
internalize exogenous antigens and transport them through the
endocytic pathway, where the internalized proteins are processed
by cathepsins and other proteases into antigenic peptides [5,6]. In
this model, loading of peptides onto MHC-I molecules occurs
directly within early and late endosomal/lysosomal compartments,
often in a transporter associated with antigen processing-
independent manner [7,8]. In the endosome-to-cytosol pathway,
internalized protein antigens are transported out of endosomes
and into the cytosol by a mechanism that may involve ER-
associated retrotranslocation complexes [9–12]. Subsequently,
protein antigens follow the classical pathway of direct MHC-I
presentation involving proteasome-mediated protein degradation
and TAP transport of antigenic peptides into the endoplasmic
reticulum (ER) for loading onto nascent MHC-I molecules [13]. A
third proposed model of cross-presentation describes a unique
intracellular compartment of exogenous antigen loading, termed
the ergosome, which involves a possible fusion of ER with
phagosomes containing internalized antigenic cargo [14,15].
Although the biogenesis of ergosomes is a matter of some dispute
[16], the concept of an ER-phagosome ‘mix’ compartment
remains an attractive model for explaining where peptide-
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concentration of exogenous antigens, presumably a crucial
prerequisite for efficient cross-presentation.
MHC-I molecules have been reported to reside within
endosomes and lysosomes of DCs [17,18], but their source and
intracellular trafficking routes have not yet been clearly defined.
Although recycling between the cell membrane and endosomal
compartments has been demonstrated for MHC-I in both in T
cells and macrophages [19,20], little is known about MHC-I
endocytic trafficking in DCs or how this relates to their function in
cross-presenation. We recently demonstrated a crucial role for a
conserved, exon 6-encoded MHC-I cytoplasmic tyrosine in DC
cross-presentation of exogenous antigens, and in the generation of
in vivo cytolytic T lymphocyte responses against viruses [21].
Although we showed that mutation of the cytoplasmic tyrosine
drastically reduced localization of MHC-I within endolysosomal
compartments of DCs, the dynamic contribution of surface MHC-
I to these compartments was not addressed. In this study, we
define the mechanism whereby MHC-I molecules gain direct
access to the intracellular compartment in DCs where peptide
loading takes place. This mechanism underlies the unique ability
of DCs to cross-present antigens and promote and initiate primary
adaptive immune responses.
Materials and Methods
MHC class I internalization in dendritic cells
All experiments involving mice have been approved and
performed in accordance with Canadian Council on Animal Care
requirements. Splenic DCs were isolated as described (21),cultured
overnight at 37uC in complete RPMI and the next day washed in
PBS 3 times, aliquoted and labeled with Fc blocker 2.4G2 Fcc III/
II (BD PharMingen) for 30 min at 4uC to exclude binding of
antibodies to Fc receptor, followed by labeling with AF6-88.5 (H-
2K
b) specific monoclonal antibody conjugated to fluorescein
isothiocyanate (FITC) for 30 min at 0uC in 96-well plates. Next,
they were incubated at 37uC and at different time points as
indicated, they were chilled to 4uC on ice before fixing in 2%
paraformaldehyde. Recovered DCs were pipetted onto coverslips,
mounted on slides and examined with a Nikon multiphoton
immunofluorescent confocal microscope (ICM).
In order to assess the kinetics of internalization of MHC-I
molecules, DCs were isolated as described, cultured at 37uC and
the next day they were washed and stained with Fc blocker
followed by AF6-88.5 (H-2K
b) and 36-7-5 (H-2K
k) antibodies (BD
Biosciences, Mississauga, ON, Canada) conjugated to FITC and
phycoerythrin (PE) respectively, at 4uC for 30 min in 96-well
plates. Next, sample cells were placed at 37uC, whereas control
cells were placed at 0uC and after different time points DCs were
washed 3 times, fixed in ethanol to preserve FITC fluorescence
and resuspended in 2% FCS PBS to reach an equal pH of 7.4 and
prevent further quenching. DCs with fluorescently labeled H-2K
b
molecules were examined using FACSCalibur
TM (Becton Dick-
inson). Data were analyzed using FlowJo software to examine the
H-2K
b and H-2K
k molecules following incubation at 37uCa sa n
indication of MHC-I internalization.
Intracellular DC colocalization and image quantification
Spleen-derived DCs from transgenic mice were aliquoted in 96-
well plates and stained with H-2K
b-FITC antibody after blocking
the Fc receptor. Next, DCs were resuspended in 200 mLo f3 7 uC
pre-warmed completed RPMI, mounted onto Poly-D-lysine pre-
coated coverslips and incubated at 37uC, allowing antibody-bound
H-2K
b molecules to internalize. At different time points, as
indicated, internalization was stopped by soaking the coverslips in
cold PBS. At the end of the last time point, all coverslips
containing DCs were treated with 2% BSA in PBS followed by
fixation with 2% paraformaldehyde. Spleen-derived DCs were
then permeabilized with 0.1% saponin in 2% BSA PBS followed
by incubation with goat anti-mouse EEA1 or LAMP-1 primary
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Secondary Alexa-568-conjugated rabbit anti-goat antibody (Mo-
lecular Probes, OR, USA) was used as a detection reagent. Isotype
control antibodies were used in all confocal microscopy experi-
ments to confirm the specificity of antibody staining. Images were
acquired using a Nikon-C1, TE2000-U ICM and the EZ-C1
software. Data were analyzed using ImageJ.1 to select single slices
and Adobe Photoshop 9.0 to merge images obtained from Red
and Green channels.
To visualize the acquisition of exogenous OVA peptide by
internalized H-2K
b molecules, DCs surface-labeled with H-2K
b-
FITC antibody as described above were incubated at 37uCi n
complete RPMI containing either 5 mg/mL ovalbumin protein
(Worthington, NJ) or bovine serum albumin control protein. Next,
DCs were mounted onto coverslips and incubated at 37uC for 6
hours, allowing ovalbumin protein uptake, processing and loading
onto H-2K
b molecules. Incubation was halted by chilling the
coverslips in ice-cold PBS. DCs were then fixed and permeabilized
as described and following Fc blocking for 30 min, they were co-
stained with goat anti-mouse EEA1, LAMP-1 or rat anti-mouse
Giantin (Golgi marker) and with anti-H-2K
b/OVA257–264 anti-
body. Goat anti mouse or Rabbit anti-goat coupled to Alexa-568
(Molecular Probes) were used to detect the endosomes-EEA1 or
lysosomes-LAMP-1 and goat anti-Rat coupled to Alexa-568 was
used to detect Giantin-Golgi. Goat anti-mouse Alexa-647 labeled
was used to visualize the H-2K
b/OVA257–264 complexes. Den-
dritic cell surface-derived MHC-I were detected by locating
intracellular fluorescent-green punctate dots present. Fluorescence
was visualized by ICM using the 488-nm (green) 568-nm (red) and
633-nm (blue) laser lines for excitation of the appropriate
fluorochromes. Data were analyzed using ImageJ.1 to select single
slices and Adobe Photoshop 9.0 to merge images obtained upon
excitation of fluorochromes obtained by red, green and blue
channels. Co-localization of three different molecules was
evaluated by the presence, intensity and distribution of the white
color resulting from the overlapping of green, red and blue.
For quantification of colocalization, a total of approximately 50
DCs were examined at 606magnification. Quantitative confocal
image analysis was done by single cell identification using Openlab
software and the relative fluorescent intensity of green, red, blue,
yellow, purple, light blue and white pixels was assessed. The
relative fluorescent intensity of all individual colors was then
expressed as percent of total fluorescence intensity.
In vitro cross-presentation and T cell proliferation
Primary DCs were isolated from bone marrow precursors of
K
bWT, D7, and DY transgenic mice, by culturing in vitro in X63-
Ag8-plasmacytoma-derived GM-CSF (gift from David Gray,
University of Edinburgh, UK) at 20 mL/10 mL of RPMI
complete media. On day 8, bone marrow derived DCs (bmDCs)
were stained with antibodies against H-2K
b (AF6.88), I-A
b
(AF6.120.1) and CD11c (HL3) (Pharmingen) to test their purity
then incubated for 6 hours with 10 mg/mL OVA or with bovine
serum albumin or synthetic immunodominant peptide OVA257–
264 as controls. Next, they were washed in cold PBS and fixed in
0.0005% glutaraldehide to preserve surface K
b/OVA257–264
complexes. B3Z T cell hybridoma (kind gift from Nilabh Shastri
at UC Berkeley) were labeled with 10 mM CFSE (Molecular
MHC-I and Antigen Loading
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5 cells were co-cultured with
OVA-pulsed transgenic mice DCs in 48-well plates at 50:50 ratio
for 24 and 48 hrs. Next, the mixed cells were washed and stained
with anti-CD3-PE labeled antibody (BD Pharmingen) to detect the
T cells and analyzed by flow cytometry. Data were acquired using
FACSCalibur
TM and the CFSE fluorescence (FL1) and CD3 (FL2)
positive populations of B3Z-T cells were analyzed with FlowJo
software to assess their proliferation.
Statistical Analysis
Student’s T test was used to compare the numbers of
fluorescently labeled H-2K
b in the cytoplasm of transgenic mouse
DCs assessed by ICM and the percent down regulation of H-2K
b
molecules in transgenic mice DCs at 0uC compared to upon
incubation at 37uC as measured by FACS. The difference between
two populations was considered statistically significant if P,0.05
(two-tailed, two sample equal variance).
Results
Constitutive internalization of MHC-I in dendritic cells is
differentially affected by cytoplasmic tail mutations
To elucidate the role of distinct cytoplasmic domain motifs in
MHC-I molecular trafficking and function in vivo, we generated
transgenic mice, described previously [21], expressing either wild
type H-2K
b (K
bWT), K
b containing a point mutation of the highly
conserved exon 6-encoded tyrosine (DY), or K
b containing a
deletion of 13 amino acids encoded by exon 7, including at least
one highly conserved serine phosphorylation site (D7, Figure 1A).
Several distinct founder lines from each of the three strains were
obtained by backcrossing the transgenic mice onto a C3H
background (haplotype H-2
k).
To determine whether DCs constitutively internalize surface
MHC-I, as has been reported for activated T lymphocytes (22), we
performed MHC-I endocytosis experiments on spleen-derived
Figure 1. Constitutive MHC-I internalization in DCs is differentially controlled by cytoplasmic tyrosine- and exon 7-dependent
mechanisms. (A) Amino acid sequences of the cytoplasmic domains of wild-type H-2K
b and the two cytoplasmic tail mutants D7 and DY. The
asterisk denotes a known conserved serine phosphorylation site. The D7 mutant contains a deletion of the 13 amino acids comprising exon 7,
indicated as dashed lines. Highlighted amino acids indicate conserved tyrosine and serine residues. TM, transmembrane domain. (B) Splenic dendritic
cells isolated from K
bWT, and D7 and DY transgenic mice were labeled with FITC-conjugated H-2K
b-specific mAb, washed, and incubated at 37uC for
the indicated time points. DCs were then imaged using confocal fluorescence microscopy to visualize internalized MHC-I-containing vesicles. Data are
representative of at least 3 images captured from 2 independent experiments.
doi:10.1371/journal.pone.0003247.g001
MHC-I and Antigen Loading
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b-specific, FITC-labeled antibodies were used to stain DCs
and internalization of labeled K
b molecules was evaluated over
time. Fluorescently-labeled intracellular vesicles appeared after
30 min in the K
bWT transgenic mice DCs and were observed in
the majority of DCs examined (Figure 1B). In contrast, DCs from
both D7 and DY transgenic mice showed an almost complete
absence of these fluorescent vesicles up to 90 minutes of chase,
indicating that spontaneous internalization of K
b molecules was
abrogated.
In order to more quantitatively measure MHC-I internalization
in DCs, we used flow cytometric analysis following staining with
labeled antibodies specific for K
b and K
k. As shown in Figure 2A,
2B, and 2C both K
b and K
k were internalized very rapidly in DCs
derived from K
bWT mice, with both molecules demonstrating
Figure 2. Quantification of MHC-I internalization in DCs. The dynamics of MHC Class I internalization is assessed by the reduced mean
fluorescence units of FITC-labeled H-2K
b surface expression. Following labeling with (A and C) FITC-conjugated H-2K
b- or (B and D) PE-conjugated H-
2K
k-specific antibodies and internalization at 37uC for the indicated time points, flow cytometric analysis was conducted to assess internalization of K
b
and K
k molecules, as measured by the reduction in FITC and PE mean fluorescence intensities over time, respectively. Data are representative of 3
different experiments performed in triplicate.
doi:10.1371/journal.pone.0003247.g002
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only 4% of labeled K
b molecules were internalized from the
surface of DY-derived DCs over the same time period (Figure 2A
and B). As an internal control for MHC-I internalization, these
DY-derived DCs efficiently internalized endogenously-expressed
wild-type K
k molecules (33% internalization at 30 minutes of
chase), albeit not as rapidly as observed for K
bWT DCs
(Figure 2C). DCs from D7 mice showed an intermediate
phenotype, with ,20% of surface K
b molecules being internalized
at 30 minutes of chase time (Figure 2A and B). These results
demonstrate that, while both the D7 and DY cytoplasmic tail
alterations led to impaired MHC-I endocytosis in DCs, point
mutation of the single conserved tyrosine residue resulted in a
much more pronounced internalization defect compared to
complete deletion of the 13 amino acids comprising exon 7.
Cytoplasmic tail motifs differentially regulate trafficking
of internalized MHC-I molecules through endocytic
compartments of DCs
In order to investigate which intracellular compartments K
b
molecules traffic through following internalization from the DC
surface, spleen-derived DCs from all transgenic mice were initially
surface-labeled at 4uC with K
b-specific mAbs. Following washing
and incubation at 37uC to induce MHC-I internalization, DCs
were fixed and permeabilized at different time points and stained
with antibodies specific for EEA-1, a marker of early endosomes,
or LAMP-1, a marker of late endosomes and lysosomes. Both wild-
type and exon 7-mutated K
b molecules showed significant
colocalization with early endosomal markers at 1.5 and 3 hours
of chase. By contrast, DY molecules showed minimal or no overlap
with early endosomes at those time points (Figures 3A to 3C).
Notably, surface DY molecules were also largely excluded from
LAMP-1-positive late endosomes and lysosomes, even at 5 hours
of chase (Figures 4A to 4D). By contrast, co-localization of surface-
derived wild-type K
b molecules with LAMP-1 became evident
after only 90 minutes of incubation at 37uC (Figure 4B).
Interestingly, although little or no colocalization of D7 molecules
with LAMP-1 could be observed at earlier time points, significant
overlap could be detected at five hours of chase (Figure 4B to 4D).
Taken together, these data indicate that while K
b molecules
lacking exon 7 show significantly delayed internalization kinetics
compared with wild-type K
b molecules, they nonetheless can
traffic from the cell surface into both early and late endosomal/
lysosomal compartments of DCs. In contrast, tyrosine point-
mutated K
b molecules were almost completely abrogated in their
ability to traffic from the cell surface to endosomal/lysosomal
compartments containing either EEA1 or LAMP-1.
Cytoplasmic tail mutations reveal distinct pathways of
MHC-I trafficking through exogenous peptide-loading
compartments of DCs
Prior to assessing the entry of surface-derived K
b molecules into
endocytic compartments, a competition assay using flow cytometry
was designed. No change in H-2K
b binding was observed with
sequential staining of K
b molecules preceded or followed by staining
of H-2K
b/OVAp complexes (refer to Supporting Information: Text
S1 and Figure S1). The same was observed for the H-2K
b/OVAp
surface expression indicating that there was no competition of these
antibodies for binding to specific sites. In order to assess how entry of
surface-derived K
b molecules into endocytic compartments coin-
cides with exogenous antigen loading, K
b surface-labeled DCs were
pulsed with soluble OVA protein for 6 hours to allow simultaneous
K
b-FITC internalization and OVA uptake and antigen processing.
DCs were then fixed, permeabilized and stained with fluorescently-
labeled antibodies specific for either EEA1, LAMP-1, or Giantin, a
Golgi marker (red) in addition to 25.D1, an antibody that specifically
stains K
b/OVA257–264 complexes (blue). Stained DCs were then
examined and imaged by confocal microscopy to assess colocaliza-
tion of the three fluorophores. In order to obtain a more precise
quantification of this colocalization, we used image analysis software
to obtain pixel counts for the seven colors present in each overlaid
confocal image [green, red, blue, yellow (g+r), light blue (g+b), pink
(r+b), and white (g+r+b)]. While Figure 5A, B and C shows confocal
DC images representative of each mouse strain, quantification of
fluorescence intensity was performed on images from a further 30 to
50 individual DCs from each mouse strain in order to generate the
quantitative data summarized in Figure 5 (D to F).
When DCs from all transgenic mice strains were incubated at
4uC, no loading of OVA peptide antigen (blue) was detectable and
K
b molecules remained at the cell surface, as expected (not
shown). Upon incubation at 37uC for 6 hrs, both surface K
b and
K
b-OVA complexes showed abundant colocalization (white) with
EEA1-positive intracellular compartments in K
bWT-derived DCs
(Figure 5A). Notably, overlapping of EEA-1 and K
b-OVA
complexes without surface K
b (indicated by pink color) was
significantly higher (p=0.002) in D7-derived DCs (Figure 5D). By
contrast, early endosomes from DY-derived DCs contained no
detectable surface-derived K
b or K
b-OVA complexes (Figure 5A).
Similarly, K
bWT-derived DCs demonstrated extensive triple
overlap of surface-derived K
b and OVA-loaded K
b molecules with
LAMP-1-positive compartments (Figure 5A). By comparison, DCs
derived from D7 and DY mice showed 2-fold (p=0.004) and 6-fold
(p=0.0001) less triple colocalization, respectively (Figures 5A and
Figure 3. MHC-I cell surface-to-endosome trafficking in DCs is
differentially abrogated by mutations in cytoplasmic tyrosine
or exon 7-encoded determinants. (A to C) Splenic DCs isolated
from K
bWT, and D7 and DY transgenic mice were mounted on
coverslips, labeled with FITC-conjugated H-2K
b-specific mAb, washed,
then incubated at 37uC for the indicated times. DCs were then fixed,
permeabilized and counterstained for EEA-1. Images were acquired
using a multiphoton fluorescence confocal microscope. Yellow color
indicates co-localization of surface-derived H-2K
b (green) with EEA-1
(red). Data are representative of at least 3 images captured from 2
independent experiments.
doi:10.1371/journal.pone.0003247.g003
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bWT-derived DCs the majority (.80%) of
LAMP-1-positive compartments also contained surface-derived
K
b, with DY-derived DCs showing approximately 5-fold less
(p=0.0001) overlap of these two markers and D7-derived DCs
demonstrating an intermediate phenotype (Figure 5E). Converse-
ly, DY-derived DCs showed a strikingly higher (p=0.006)
percentage of LAMP-1 alone (red pixels, not colocalized with
the other two markers) compared with K
bWT-derived DCs.
Co-staining with the Golgi marker Giantin showed very little
colocalization of surface K
b or K
b-OVA complexes with Golgi in
DCs from K
bWT and D7 mice. Interestingly, in DY-derived DCs,
Giantin and surface K
b demonstrated a significant (p=0.0004)
degree of overlap (yellow) and some triple colocalization (white)
(p=0.007) was also apparent (Figures 5C and 5F).
In summary, while surface K
bWT molecules appear to form an
abundant source of MHC-I molecules for early and late
endosomal peptide-loading, surface DY molecules do not gain
access to these peptide-loading sites due to aberrant intracellular
trafficking. Surface K
b molecules that lack exon 7, by contrast,
appear to traffic readily into early endosomal compartments, but
are significantly delayed in their ability to traffic into late
endosomes or lysosomes. Taken together, these data reveal distinct
intracellular trafficking patterns for K
bWT, D7 and DY molecules
in DCs that may provide a plausible mechanism to explain their
different abilities to cross-present exogenous antigens.
Cross-presentation and T cell activation is impaired in
DY-derived DCs following 6 hour incubation with OVA
antigen
To correlate the impaired intracellular trafficking of MHC
Class I molecules in our transgenic mouse DCs with functional
impairment of OVA cross-presentation and T cell activation
during the 6 hour time period, T cell proliferation was monitored
for 48 hours following a 6 hour incubation of transgenic mouse
DCs with OVA protein. Proliferation of CFSE-labeled T cells was
detectable following 24 hours of co-incubation with K
bWT
transgenic OVA-pulsed DCs (Figure 6A). However, fewer T cells
proliferated following incubation with D7-derived DCs while this
was barely measurable following co-culture with DY-DCs. After 48
hours, more then half of the T cells incubated with K
bWT-DCs
Figure 4. MHC-I cell surface-to-lysosome trafficking in DCs is impaired by mutation in the cytoplasmic tyrosine residue. (A to D)
Splenic DCs isolated from K
bWT, and D7 and DY transgenic mice were mounted on coverslips, labeled with FITC-conjugated H-2K
b-specific mAb,
washed, and incubated at 37uC for the indicated times. DCs were then fixed, permeabilized, and counterstained for LAMP-1. Yellow color indicates co-
localization of surface-derived H-2K
b (green) with LAMP-1 (red). Data are representative of at least 3 images captured from 2 independent
experiments.
doi:10.1371/journal.pone.0003247.g004
MHC-I and Antigen Loading
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considerable fraction of T cells incubated with D7-DCs were
dividing. However, when T cells were incubated with DY-DCs,
over 90% of them did not proliferate indicating that cross-
presentation of OVA antigen and T cell activation was severely
impaired presumably due to defective internalization and
intracellular trafficking of surface DY-K
bs. No difference in T cell
activation was observed, between transgenic mice DCs following
their incubation with OVA257–264.
Discussion
Although cross-presentation by DCs is a crucial prerequisite for
effective priming of cytotoxic T-cell responses against bacterial,
viral, and tumor antigens in vivo, several mechanistic aspects of
these pathways remain poorly defined. The results presented here
delineate constitutive pathways of MHC-I intracellular transport
in DCs, and illuminate the nature of the intracellular compart-
ments of DCs where peptides from exogenously-derived antigens
Figure 5. Cytoplasmic tail mutations significantly reduce the contribution of surface MHC-I molecules to endosomal and lysosomal
peptide-loading compartments. (A to C) Splenic DCs isolated from K
bWT, D7, and DY transgenic mice were labeled with FITC-conjugated H-2K
b-
specific mAb, washed and incubated for 6 hr at 37uC in 5 mg/mL ovalbumin protein. DCs were then labeled with mAbs specific for (A) early
endosomal antigen, EEA-1, (B) lysosomal marker LAMP-1 and (C) Golgi marker Giantin. All DCs were simultaneously co-stained with purified 25.D1.16
(anti-H-2K
b/OVA257–264) antibody. Cellular markers EEA-1, LAMP-1 and Giantin were visualized by staining with secondary antibodies coupled to
Alexa-568 (red) whereas H-2K
b/OVA257–264 complexes were visualized by staining with secondary antibody conjugated to Alexa-647 (blue). Three-
color fluorescence was detected by laser scanning confocal microscopy of 488-nm (green), 568-nm (red), and 633-nm (blue) wavelengths.
Photographs depict three-color image overlays to assess colocalization of the three markers. White color indicates a triple overlap of all three markers
(green+red+blue), whereas yellow (green+red), pink (red+blue), and light blue (green+blue) indicate overlap of two of the three markers. Dt oF
shows a quantitative assessment of internalized MHC-I and MHC-I/peptide complexes within intracellular compartments of DCs. Three-color confocal
overlay images of DCs, as shown in Figure 5, were analyzed for relative fluorescent color (pixel) intensity in order to obtain a quantitative measure of
fluorophore colocalization. For each data set, 30 to 50 individual DCs derived from each of the indicated mouse strains were analyzed. The green
color indicates surface-labeled H-2K
b, the blue color indicates K
b-OVA257–264 peptide complexes, and red color indicates either (A) early endosomal
antigen (EEA-1), (B) LAMP-1, or (C) Giantin. White pixels indicate triple overlap of all three markers (green+red+blue), whereas yellow (green+red),
pink (red+blue), and light blue (green+blue) indicate overlap of two of the three markers. Graph depicts individual color pixel mean percentages and
standard deviations, as calculated by dividing the number of pixels of a given color by the total number of colored pixels counted. Data are
representative of at least 3 images captured from 4 independent experiments.
doi:10.1371/journal.pone.0003247.g005
MHC-I and Antigen Loading
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data demonstrate that MHC Class I from the cell surface can enter
a vesicular compartment that contains also complexes of MHC
Class I and cross-presented antigen.
Our microscopic analysis of spleen-derived DCs reveals for the
first time, that wild-type (WT) surface MHC-I molecules are
internalized and transported to early and late endosomal/
lysosomal compartments, where peptides from exogenously-
derived antigens can be loaded [13,18,21,22]. While efficient
MHC Class I loading with exogenous antigen has been shown to
occur in early endosomes (13), some endosome-to-lysosome
trafficking or exchange of MHC Class I containing antigenic
peptide, can not be excluded particularly at later time points (6 hr)
that could be occurring during fusion of endocytic compartments
while processing the exogenous antigen. However, in this model, it
is difficult to assess the relevance of MHC Class I that contain
antigenic peptide in late endosomes for priming T cells. Our
functional data indicate that peptide-loaded K
b molecules, can
reach the cell surface within 6 hours, and are sufficient to induce T
cell proliferation. While microscopy could somewhat visualize the
peptide-loaded K
bs on the cell surface, this was not convincingly
quantifiable and therefore the assessment of T cell activation
complemented the previous observations and revealed the
relevance of their presence on the cell surface within the time
frame assessed. Also, our model including the 6 hour time frame,
tends to validate the vacuolar pathway of antigen presentation
since it allows little time for the antigen to access the cytosol,
although as shown by microscopy and some minimal T cell
activation in DY-DCs, this could occur even at early time points.
Consequently, it is reasonable to assume that this pathway may
account for the first wave of T cells that are generated following
antigen exposure during the immune response. Importantly in the
present study we can clearly demonstrate that this pathway is
dependent on the conserved cytoplasmic tyrosine residue encoded
by exon 6, confirming its role as part of a tyrosine-based endocytic-
sorting motif (YXXA) that controls endocytic trafficking of surface
MHC-I molecules [23]. It is thus likely that the previously
reported cross-presentation deficiency in DY-derived DCs resulted
from the inability of these tyrosine-mutated surface K
b molecules
to traffic through endocytic loading compartments (ELCs) [21].
Our data also demonstrates a distinct role for exon 7-encoded
amino acids in controlling MHC-I intracellular trafficking in DCs.
The existence of exon 7-deleted MHC-I isoforms that lack
conserved serine phosphorylation sites has been reported in several
species including mouse, arising in different cell types to varying
degrees as a result of differential RNA splicing [24]. As has
previously been reported for lymphoblastoid cell lines, exon 7-
deleted (D7) MHC-I molecules in DCs show significantly delayed
kinetics of internalization from the cell surface [25]. However,
unlike DY, surface D7 molecules do possess the ability to traffic
though both early and late endosomal compartments, albeit more
slowly than K
bWT molecules. Delayed cell surface internalization
may actually provide an advantage by prolonging antigen
presentation to augment CTL priming, a notion consistent with
our previous observation that D7 mice consistently generated more
vigorous antiviral CTL responses compared to K
bWT mice [21].
The distinct intracellular localizations of newly-formed K
b-
OVA complexes observed in K
bWT, D7, and DY-derived DCs
support the emerging concept of multiple pathways of peptide
loading of cross-presented antigens [26,27]. In our study, the
majority of K
bWT-OVA complexes were found within early and
late endosomal/lysosomal compartments of DCs after exposure to
OVA. Like K
bWT, the majority of D7-OVAp complexes were
also found within early and late endosomes. By contrast, DY-
OVAp complexes were comparatively less abundant, and those
observed were almost exclusively in non-endolysosomal compart-
ments, with some appearing in the Golgi and others colocalizing
with the ER marker Grp78 (unpublished).
Our data suggests that the vacuolar pathway of exogenous
antigen loading plays a principal role in cross-presentation, having
observed the majority of K
bWT-OVA complexes within early and
late endosomes/lysosomes of DCs following addition of soluble
ovalbumin. However, the existence of K
b-OVA complexes within
non-endolysosomal compartments, as seen in both D7 and DY
DCs, suggests that a second compartment of exogenous antigen
loading also exists. These observations could support the
endosome-to-cytosol pathway, in which exogenous antigens are
extruded into the cytosolic pool of protein antigens and are
processed by proteosomes before being transported into the ER for
loading onto nascent MHC-I molecules. However, co-localization
analysis of K
b-OVA complexes with the ER marker Grp78 showed
that only a minor fraction of Grp78-positive compartments
contained such complexes, and these compartments also coloca-
lized with surface-derived K
b molecules (unpublished data). This
could be interpreted as evidence of ‘‘ergosomal’’ peptide loading, in
which the relevant loading sites consist of mixed compartments
containing markers of both ER and endolysosomes [28]. While it
remains disputed whether phagosomal membranes are ER- or
plasma membrane-derived [16], it is possible that cross presenta-
tion-competent, ergosomal organelles may be formed through
another mechanism of vesicular fusion, following endocytosis.
Further studies utilizing different ER specific markers will need to
be performed before definitive conclusions can be reached.
Figure 6. T cell activation is severely compromised in protein-
pulsed DCs of transgenic mice containing the cytoplasmic tail
mutation. bmDCs from K
bWT, D7 and DY transgenic mice were
isolated, incubated for 6 hours with 10 mg/mL OVA and co-cultured for
24 and 48 hours with B3Z-T hybridoma cells previously labeled with
1 mM of CFSE. Mixed cultures were then stained with anti-CD3-PE
antibody and flow cytometry was conducted to examine the CFSE/CD3
+
T cell population and proliferation. Histograms depict proliferating T
cells following incubation with OVA-pulsed DCs (including one
representative of OVA257–264) of transgenic mice for 24 (A) and 48 (B)
hours. Data are representative of 1 experiment performed in triplicate.
doi:10.1371/journal.pone.0003247.g006
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PLoS ONE | www.plosone.org 8 September 2008 | Volume 3 | Issue 9 | e3247Figure 7. Model of dendritic cell MHC-I trafficking and cross-presentation. Schematic representation of trafficking routes for K
bWT, D7, and DY
molecules in dendritic cells, depicting proposed intracellular sites of antigen acquisition. In the direct presentation pathway (bottom),e n d o g e n o u s l y -
synthesized proteins (green) are degraded by cytosolic proteosome complexes into antigenic peptides, which are transported by the transporter
associated with antigen processing (TAP) into the endoplasmic reticulum (ER) for binding to nascent class Ia chain/b2-microglobulin dimers. K
bWT, D7,
andDYmoleculesinitiallyloadedintheERwithendogenously-derivedpeptides(green)arethentransportedthroughthecis-andtrans-Golgi(TGN)andto
the cell surface via the secretory pathway. Alternatively, a subset of K
bWT and D7, but not DY, molecules may be re-routed from the secretory pathway
directly into endolysosomal compartments, although this pathway remains largely uncharacterized. In cross-presentation, exogenous protein antigens
(orange, top) are internalized into endocytic vesicles, where they can be transported into the cytosol via ER-associated retrotranslocation (asterisk) and
subsequently enter the direct presentation pathway. Exogenous antigens may also be transported into endolysosomes, where they are degraded by
resident proteases and Cathepsin S into antigenic peptides (orange). Surface MHC-I molecules are constitutively internalized and transported through the
endocytic pathway by a mechanism that requires the MHC-I cytoplasmic tyrosine (Y) residue. MHC-I molecules lacking Exon 7 (Ex7), despite abundant
colocalization within endosomes and lysosomes, are significantlydelayed in their endocytic transport. MHC-I transport through early endosomes and late
endosomes/lysosomes seems to be required for acquisition and cross-presentation of exogenously-derived peptides, suggesting that such peptides are
bound to recycling MHC-I molecules directly within endocytic loading compartments (ELCs).
doi:10.1371/journal.pone.0003247.g007
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trafficking and exogenously-derived peptide loading depicted in
Figure 7. In this model, K
bWT, D7, and DY molecules initially
appear in the ER as nascent MHC-I heavy chains that bind to b2-
microglobulin and are loaded primarily with endogenously-
derived peptides generated by the proteosome and transported
by TAP. After secretory transport through the Golgi and to the cell
surface, wild-type K
b molecules are rapidly and efficiently
internalized and transported to ELCs, where peptide exchange
and loading of peptides from exogenously-derived antigens
generated by endolysosomal proteases and cathepsins may occur.
These newly-loaded MHC-I complexes are then transported by an
undefined mechanism back to the cell surface for cross-
presentation to T cells. By contrast, K
b molecules lacking exon 7
are internalized and transported to ELCs, but significantly more
slowly than wild-type molecules. Interestingly, this delayed kinetics
does not seem to significantly reduce the level of D7 molecules
residing within ELCs. This raises the possibility that MHC-I
molecules might gain access to endolysosomal compartments by
means other than internalization from the cell surface. The
relative abundance of D7-OVA complexes in ELCs that are not
colocalized with surface-derived D7 molecules (Figures 5A and 5B,
pink color) supports this notion. This may indicate loading of
newly-synthesized MHC-I molecules through the classical path-
way and subsequent transport to endosomes, or alternatively may
represent loading of nascent K
b molecules within ELCs. MHC-I
molecules may conceivably traffic to ELCs directly from the ER to
create ergosomal mix/fusion compartments, but this pathway is
not currently well understood [29]. Another potential trafficking
route may involve sorting of MHC-I molecules from the trans-
Golgi into endolysosomes, a pathway that has been well-described
for other transmembrane proteins [30]. It is tempting to speculate
that the DY molecules we observed in Golgi compartments of DCs
may be trapped there as a result of their inability to interact with
the appropriate tyrosine motif-binding adaptin proteins to be
sorted into clathrin-coated vesicles destined for ELCs [31].
While the results presented here provide an important first step
for delineating intracellular routes of MHC-I trafficking in DCs
and defining the molecular mechanisms that contribute to cross-
presentation, many questions remain unresolved. For example, it
will be interesting to examine whether serine phosphorylation is
the major mechanism that modulates MHC-I internalization and
recycling, and whether tyrosine phosphorylation also plays a role
[32]. DC maturation stimuli (ie. TLR ligands) that induce changes
in MHC-I molecular trafficking and remodeling of intracellular
compartments will also shed light on how specialized exogenous
antigen loading can occur with maximum efficiency [33]. Finally,
there are unresolved questions regarding the importance of
antigen entry route on cross-presentation. Soluble ovalbumin has
recently been shown to be dependent upon the mannose receptor
for its uptake into DCs (13). It will be interesting to determine
whether the MHC-I cytoplasmic domain plays a similar role in the
cross-presentation of pinocytosed or phagocytosed antigens as well
as the MHC Class I targeting in the organelle where loading takes
place following distinct routes of uptake’. With growing evidence
that cross-presentation is crucial for the generation of appropriate
CD8
+ immune responses, future work should focus on uncovering
the relevant mechanisms and better characterizing the dynamic
nature of cross-presentation compartments. Understanding these
issues will ultimately lead to the development of more potent
dendritic cell-based vaccines for cancer and other diseases, as well
as novel strategies to target endogenous DCs in vivo to generate
optimal CD8
+ T-cell priming against defined antigens.
Supporting Information
Text S1
Found at: doi:10.1371/journal.pone.0003247.s001 (0.02 MB
DOC)
Figure S1 DC2.4 dendritic cells were incubated with 1 mM
OVA257–264 or PBS and labeled sequentially with anti-H-2K
b-
FITC followed by anti H-2K
b/OVA257–264 antibodies and vice
versa. Flow cytometry was conducted to assess the H-2K
b and H-
2K
b/OVA257–264 complexes. Data represents one experiment.
Found at: doi:10.1371/journal.pone.0003247.s002 (0.06 MB TIF)
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